Skip to main content
. 2024 Jul 22;16(14):2368. doi: 10.3390/nu16142368

Table 1.

Study patients’ demographics.

All Patients
(n = 55)
Placebo
(n = 28)
PA
(n = 27)
p-Value
Age, y 50.4 (±11.6) 51.8 (±11.1) 49.1 (±11.9) 0.395
Females 39 (70.1%) 21 (75%) 18 (66.7%) 0.778
Body Mass Index * 27.1 (±4.3) 26.4 (±3.7) 27.7 (±4.7) 0.268
Medical history
   Diabetes 1 0 1 0.313
   Hypertension 11 4 7 0.378
Cholesterol levels (mg/dL)
   Total (mg/dL) 256.9 (±43.3) 263.1 (±36.1) 250.4 (±48.7) 0.284
   LDL (mg/dL) 184.7 (±41) 188.3 (±34.9) 181.2 (±46.3) 0.53
   HDL (mg/dL) 67.2 (±20.8) 72.8 (±20.1) 61.3 (±19.8) 0.047

Data are presented as mean ± standard error of mean (SEM). * Body mass index was calculated by weight in kilograms divided by the square of height in meters.